article thumbnail

Biogen agrees to pay $900 million in largest FCA Settlement Ever Secured without Government’s Intervention

FDA Law Blog

district court of Massachusetts by former employee and whistleblower Michael Bawduniak in April 2012 as a qui tam action. HHS noticed an increasing trend of illegal kickbacks in connection with speaker programs and in November 2020, the Office of Inspector General issued a Special Fraud Alert on the topic. See United States ex rel.

article thumbnail

Episode 384: Antiracism in Medicine – Episode 26 – Racial and Gender Health Disparities in Youth Suicide: Part 1

The Clinical Problem Solvers

These programs recognize the increasing difficulties in having to first see a community-based primary care provider before seeing a specialized psychiatrist. Suicide Trends Among Elementary School-Aged Children in the United States From 1993 to 2012. JAMA Netw Open. 2020;3(8):e2013100. doi:10.1001/jamanetworkopen.2020.13100

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Long Time Passing: Where Have All the De Novo Decision Summaries Gone?

FDA Law Blog

The De Novo process provides a regulatory pathway to classify novel devices for which general controls alone or general and special controls provide reasonable assurance of safety and effectiveness for the intended use. The classification order identifies the special controls and therefore is extremely important.

article thumbnail

Critics Suggest FDA Approving Aduhelm Will Erode the “Public Trust”: What About Patients’ Trust?

FDA Law Blog

For 6 years, I served as a patient liaison within FDA in what was then called the Office of Special Health Issues. Over the years, this function expanded to cancer (renamed the Office of AIDS and Special Health Issues) and, ultimately, all serious and life-threatening diseases (dropping the AIDS nomenclature).

article thumbnail

Older adults with advanced chronic kidney disease and access to palliative care: Retrospective cohort study in primary care

Canadian Family Physician

Participants Older adults who are 65 years of age or older with advanced CKD and undergoing community-based nondialysis kidney care between April 1, 2012, and April 1, 2022, with at least 1 year of follow-up.

article thumbnail

Agitation Podcast Series Episode 2: Non-pharmacologic management of agitated children

PEMBlog

Special thanks to Manpreet Singh, MD ( @MprizzleER ) for helping to put this collaboration together. 2012 Jan;109(3):27-32. 2012 Feb;13(1):35-40. These articles will take another look at the content included in this episode. Deaths due to physical restraint. Dtsch Arztebl Int. PMC3272587. Coburn VA, Mycyk MB. doi: 10.1016/j.emc.2009.07.003.

article thumbnail

Does the Drug Shortage White Paper Fall Short?

FDA Law Blog

In its report, Drug Shortages: Root Causes and Potential Solutions, FDA explains that the equipment needed to produce sterile injectables is highly specialized and expensive, meaning that in a shortage situation, production capacity cannot be substantially increased without taking the time and expense of procuring and qualifying new equipment.